These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 36311753)

  • 1. Identification of hub genes and their correlation with infiltration of immune cells in
    Chen J; Sun M; Chen C; Jiang B; Fang Y
    Front Immunol; 2022; 13():1016683. PubMed ID: 36311753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics-Based Identification of Key Prognostic Genes in Neuroblastoma with a Focus on Immune Cell Infiltration and Diagnostic Potential of VGF.
    Guo Q; Xiao Y; Chu J; Sun Y; Li S; Zhang S
    Pharmgenomics Pers Med; 2024; 17():453-472. PubMed ID: 39403102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
    Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
    Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Druggable epigenetic suppression of interferon-induced chemokine expression linked to
    Seier JA; Reinhardt J; Saraf K; Ng SS; Layer JP; Corvino D; Althoff K; Giordano FA; Schramm A; Fischer M; Hölzel M
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
    Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
    J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
    Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma.
    Weng Z; Lin J; He J; Gao L; Lin S; Tsang LL; Zhang H; He X; Wang G; Yang X; Zhou H; Zhao H; Li G; Zou L; Jiang X
    Neuro Oncol; 2022 Jun; 24(6):872-885. PubMed ID: 34655293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning methods revealed the roles of immune-metabolism related genes in immune infiltration, stemness, and prognosis of neuroblastoma.
    Mu J; Gong J; Lin P; Zhang M; Wu K
    Cancer Biomark; 2023; 38(2):241-259. PubMed ID: 37545226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN.
    Yang R; Liu N; Li T; Liu F; Zhang J; Zhao H; Zou L; He X
    J Transl Med; 2023 Sep; 21(1):659. PubMed ID: 37741985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
    Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
    Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma.
    Yang L; Huang K; Cao L; Ma Y; Li S; Zhou J; Zhao Z; Wang S
    Inflamm Res; 2024 Sep; 73(9):1529-1545. PubMed ID: 39028490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of
    Shao F; Wang Z; Wang S
    DNA Cell Biol; 2021 Feb; 40(2):332-347. PubMed ID: 33393844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
    Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
    Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analysis of hub markers and immune cell infiltration characteristics of gastric cancer.
    Li C; Yang T; Yuan Y; Wen R; Yu H
    Front Immunol; 2023; 14():1202529. PubMed ID: 37359529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comprehensive analysis of potential prognostic biomarkers for MYCN-amplified neuroblastoma].
    Fan X; Lu HT; Hou L; Zhang L; Yang BY; Chen WM; Zhang HY; Chen X; Li FJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):262-268. PubMed ID: 32204764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma.
    Agarwal P; Glowacka A; Mahmoud L; Bazzar W; Larsson LG; Alzrigat M
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma.
    Hallett RM; Seong AB; Kaplan DR; Irwin MS
    Mol Oncol; 2016 Nov; 10(9):1461-1472. PubMed ID: 27599694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
    Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
    Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signature based on five immune-related genes to predict the survival and immune characteristics of neuroblastoma.
    Ma K; Zhang P; Xia Y; Dong L; Li Y; Liu L; Liu Y; Wang Y
    BMC Med Genomics; 2022 Nov; 15(1):242. PubMed ID: 36419120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.